Coverage
-
August 02, 2021
A now-defunct diabetic testing equipment supplier last owned by Abbott Laboratories will cough up $160 million to settle claims that it wrongly paid kickbacks and also charged Medicare for unnecessary equipment, according to the federal government.
1 other articles on this case.
View all »